Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QLT, a global biopharmaceutical company, has appointed Kathryn Falberg to its board of directors and audit committee. Ms Falberg appointment brings the board membership to seven directors.
Subscribe to our email newsletter
Ms Falberg is currently CFO and COO of Arca biopharma and has over 20 years of experience as a financial executive and corporate director.
Ms Falberg’s career includes seven years at Amgen, where she served as senior vice president and CFO, as well as vice-president, controller and chief accounting officer and treasurer.
Ms Falberg currently serves as chair of the audit committees for Halozyme and ESS Technology. Ms Falberg has received a BA and an MBA from the University of California, Los Angeles.
Boyd Clarke, chairman of the board at QLT, said: “Kate brings a wealth of experience and we are pleased to welcome her to our board. Kate brings a robust financial and strategic skill set and strong industry background in biotechnology. We believe that QLT will greatly benefit from Kate’s operational and financial experience.”